Chronic fatigue syndrome

Wright, J. B.; Beverley, D W

doi:10.1136/adc.79.4.368

Cited by 31 publications

(18 citation statements)

References 65 publications

(95 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We chose to focus on girls because fatigue and fatigue-related syndromes are especially present in female individuals. 1,20,35,36 Nevertheless, it would be interesting to investigate whether the same factors are involved in fatigue development and persistence in boys as in girls. Finally, we used self-reports to investigate the severity of depression and anxiety and CFS-related symptoms.…”

Section: Discussionmentioning

confidence: 96%

Predictors of Persistent and New-onset Fatigue in Adolescent Girls

et al. 2008

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 96%

Predictors of Persistent and New-onset Fatigue in Adolescent Girls

et al. 2008

View full text Add to dashboard Cite

show abstract

“…[4][5][6][7] The pathogenesis and etiology of CAEBV syndrome are not well characterized, and it is not clear whether the defect lies in the virus or in the host response. [13][14][15] This lack of information has hampered the development of effective therapies. Sporadic clinical improvements have been reported after infusion of interleukin 2 (IL-2), high-dose immunoglobulin, antiviral drugs, or steroids, but these results have been hard to replicate.…”

Section: Introductionmentioning

confidence: 99%

Autologous Epstein-Barr virus (EBV)–specific cytotoxic T cells for the treatment of persistent active EBV infection

Savoldo¹,

Huls

Liu

et al. 2002

Blood

137

View full text Add to dashboard Cite

Chronic active Epstein-Barr virus (CAEBV)infection syndrome is a heterogeneous EBV-related disorder characterized by chronic fatigue, fever, lymphadenopathy, and/or hepatosplenomegaly, associated with abnormal patterns of antibody to EBV. CAEBV can range from disabling mild/moderate forms to rapidly lethal disorders. Even patients with mild/moderate disease frequently suffer adverse effects from long-term anti-inflammatory agents and have a quality of life that progressively deteriorates. It is still unknown why these individuals are unable to produce an effective immune response to control EBV, and no effective treatment is currently available. Since ex vivo-expanded EBV-specific cytotoxic T lymphocytes

show abstract

“…We would strongly recommend a well designed and larger multicentre trial. Toys and potentially lethal games A 15 year old was brought to our emergency department with mild headache after having been shot at contact range with an air pistol. Examination revealed a circular entry wound of 1 cm on the forehead without a corresponding exit wound.…”

Section: Discussionmentioning

confidence: 99%